111, Inc. (YI)
NASDAQ: YI · Real-Time Price · USD
3.170
-0.523 (-14.16%)
At close: Dec 22, 2025, 4:00 PM EST
3.160
-0.010 (-0.32%)
After-hours: Dec 22, 2025, 4:10 PM EST
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $27.48 million as of December 22, 2025. Its market cap has decreased by -59.49% in one year.
Market Cap
27.48M
Enterprise Value
-13.19M
1-Year Change
-59.49%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.11B to $27.48M, a decrease of -97.53%. That is a compound annual growth rate of -39.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 32.01M | -40.02% |
| Dec 31, 2024 | 53.37M | -59.01% |
| Dec 29, 2023 | 130.19M | -48.23% |
| Dec 30, 2022 | 251.48M | -13.30% |
| Dec 31, 2021 | 290.06M | -49.33% |
| Dec 31, 2020 | 572.40M | 4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 953.70B |
| Johnson & Johnson | 498.90B |
| AbbVie | 400.90B |
| UnitedHealth Group | 296.81B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 255.95B |
| Abbott Laboratories | 220.31B |